AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 344,968 Value ($000) $4,167 Avg Close $13.58 Range $11.69 - $16.96
Q3 2025
Shares 234,673 Value ($000) $3,189 Avg Close $9.41 Range $5.97 - $15.14
Q2 2025
Shares 1,242,927 Value ($000) $7,967 Avg Close $4.86 Range $3.11 - $6.70
Q1 2025
Shares 2,757,776 Value ($000) $9,763 Avg Close $3.56 Range $2.60 - $4.18
Q4 2024
Shares 1,970,704 Value ($000) $7,449 Avg Close $4.71 Range $2.91 - $7.27
Q3 2024
Shares 1,899,560 Value ($000) $6,155 Avg Close $2.25 Range $1.62 - $3.33
Q2 2024
Shares 1,344,818 Value ($000) $2,555 Avg Close $1.94 Range $1.57 - $2.89
Q1 2024
Shares 1,330,384 Value ($000) $3,778 Avg Close $13.08 Range $2.67 - $19.95
Q4 2023
Shares 2,240,885 Value ($000) $32,986 Avg Close $15.33 Range $11.82 - $18.88
Q3 2023
Shares 1,226,944 Value ($000) $22,465 Avg Close $21.15 Range $17.80 - $25.48
Q2 2023
Shares 813,325 Value ($000) $17,543 Avg Close $27.01 Range $20.79 - $31.77
Q1 2023
Shares 228,906 Value ($000) $6,716 Avg Close $34.74 Range $26.64 - $41.93
Q4 2022
Shares 56,757 Value ($000) $2,097 Avg Close $35.49 Range $28.13 - $39.77
Q3 2022
Shares 806,830 Value ($000) $22,712 Avg Close $24.95 Range $15.80 - $32.80
Q2 2022
Shares 754,410 Value ($000) $14,529 Avg Close $11.87 Range $6.51 - $20.74
Q1 2022
Shares 501,636 Value ($000) $6,446 Avg Close $22.45 Range $10.49 - $33.41